IL95279A - 4-] Cycloalkylene-1-) imidazolil or triazolil (methyl [- benzonitriles and their history, processes for their preparation and pharmaceutical preparations containing them - Google Patents

4-] Cycloalkylene-1-) imidazolil or triazolil (methyl [- benzonitriles and their history, processes for their preparation and pharmaceutical preparations containing them

Info

Publication number
IL95279A
IL95279A IL9527990A IL9527990A IL95279A IL 95279 A IL95279 A IL 95279A IL 9527990 A IL9527990 A IL 9527990A IL 9527990 A IL9527990 A IL 9527990A IL 95279 A IL95279 A IL 95279A
Authority
IL
Israel
Prior art keywords
methyl
imidazolyl
benzonitrile
cycloalkylene
triazolyl
Prior art date
Application number
IL9527990A
Other languages
English (en)
Hebrew (he)
Other versions
IL95279A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL95279A0 publication Critical patent/IL95279A0/xx
Publication of IL95279A publication Critical patent/IL95279A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9527990A 1989-08-04 1990-08-03 4-] Cycloalkylene-1-) imidazolil or triazolil (methyl [- benzonitriles and their history, processes for their preparation and pharmaceutical preparations containing them IL95279A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926365A DE3926365A1 (de) 1989-08-04 1989-08-04 Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln

Publications (2)

Publication Number Publication Date
IL95279A0 IL95279A0 (en) 1991-06-30
IL95279A true IL95279A (en) 1995-03-30

Family

ID=6386820

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9527990A IL95279A (en) 1989-08-04 1990-08-03 4-] Cycloalkylene-1-) imidazolil or triazolil (methyl [- benzonitriles and their history, processes for their preparation and pharmaceutical preparations containing them

Country Status (19)

Country Link
US (3) US5135937A (ja)
EP (1) EP0411735B1 (ja)
JP (1) JP3207417B2 (ja)
CN (1) CN1024345C (ja)
AT (1) ATE122662T1 (ja)
AU (1) AU634266B2 (ja)
CA (1) CA2022682C (ja)
DD (1) DD296917A5 (ja)
DE (2) DE3926365A1 (ja)
DK (1) DK0411735T3 (ja)
ES (1) ES2074530T3 (ja)
FI (1) FI920425A0 (ja)
HU (2) HU217126B (ja)
IE (1) IE902843A1 (ja)
IL (1) IL95279A (ja)
NO (1) NO301115B1 (ja)
PT (1) PT94884B (ja)
WO (1) WO1991001975A1 (ja)
ZA (1) ZA906150B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
TW224461B (ja) * 1990-09-18 1994-06-01 Ciba Geigy Ag
DE4107038A1 (de) * 1991-03-01 1992-09-03 Schering Ag Triheteroarylmethane, verfahren zu deren herstellung, pharmazeutische praeparate die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
DE4120107A1 (de) * 1991-06-14 1992-12-17 Schering Ag Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
WO2001012206A2 (de) * 1999-08-13 2001-02-22 Heinrich Wieland Soja-glycine extracten und aromatase-hemendern zur positiven beeinflussung von kollagen
WO2007100346A1 (en) * 2005-07-06 2007-09-07 Sicor, Inc. Improved process for the preparation of letrozole
CN100425621C (zh) * 2006-07-06 2008-10-15 云南大学 甾体咪唑盐类化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles

Also Published As

Publication number Publication date
NO920432D0 (no) 1992-02-03
AU6019490A (en) 1991-02-07
EP0411735B1 (de) 1995-05-17
HU9200324D0 (en) 1992-04-28
CN1024345C (zh) 1994-04-27
IE902843A1 (en) 1991-02-27
NO301115B1 (no) 1997-09-15
EP0411735A1 (de) 1991-02-06
US5135937A (en) 1992-08-04
HUT59911A (en) 1992-07-28
HU217126B (hu) 1999-11-29
DK0411735T3 (da) 1995-10-16
NO920432L (no) 1992-02-03
ATE122662T1 (de) 1995-06-15
AU634266B2 (en) 1993-02-18
US5280035A (en) 1994-01-18
CA2022682A1 (en) 1991-02-05
JP3207417B2 (ja) 2001-09-10
WO1991001975A1 (de) 1991-02-21
IL95279A0 (en) 1991-06-30
PT94884B (pt) 1997-04-30
DE3926365A1 (de) 1991-02-07
CN1049157A (zh) 1991-02-13
DD296917A5 (de) 1991-12-19
DE59009084D1 (de) 1995-06-22
ES2074530T3 (es) 1995-09-16
ZA906150B (en) 1991-05-29
CA2022682C (en) 1997-01-21
FI920425A0 (fi) 1992-01-30
PT94884A (pt) 1991-04-18
JPH05501104A (ja) 1993-03-04
US5411982A (en) 1995-05-02

Similar Documents

Publication Publication Date Title
US4935437A (en) (Substituted aralkyl) heterocyclic compounds
EP0337928A1 (de) N-substituierte Imidazole, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
EP0073663A2 (en) Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
HU194839B (en) Process for production of derivatives of triasole and imidasole and medical preparatives containing such compounds
US4916148A (en) Naphtho(2,1-b) furan derivatives
US5135937A (en) Cycloalkylene azoles and pharmaceutical preparations obtained therefrom
EP0054417A1 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
NO168033B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive triazol-og imidazol-derivater.
US4910212A (en) Heterocyclic compounds
NO310237B1 (no) Nye selektive aromatase-inhiberende forbindelser, farmasöytisk preparat og anvendelse av forbindelsene
IE58352B1 (en) Benzocycloalkane derivatives
EP0069513A2 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
US5376669A (en) α-fluoro-α-(1,2,3-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors
US5344834A (en) Functionalized vinyl azoles and methods of use
IE921936A1 (en) Bicyclic-substituted vinylimidazoles, -triazoles and¹-tetrazoles
CA2105175A1 (en) Triheteroarylmethanes, method for preparing them, pharmaceutical preparations containing them and their use to manufacture drugs
HU209302B (en) Method for producing dihydro-benzo-(b)-thiphenes and pharmaceutical preparatives containing these compounds
JPH07138160A (ja) アゾール誘導体を含有する抗アロマターゼ剤
HUT72299A (en) Novel selective aromatase inhibiting heterocyclic compounds, pharmaceutical compositions containing them and process for preparing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees